Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shah

Showing results (31-40 of 3,190) with videos related to

Pageof 319
Sort By:
Annals of Surgery|June 23, 2001
Re: Orozco et al. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy and surgery. A prospective, controlled, and randomized trial during 10 years. Ann Surg 2000; 232:216-9S R Shah
Journal of Clinical Pharmacy and Therapeutics|March 14, 2020
Genotype-guided warfarin therapy: Still of only questionable value two decades onRashmi R Shah
Drug Safety|January 17, 2019
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in OncologyRashmi R Shah
Novartis Foundation Symposium|July 30, 2005
Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studiesRashmi R Shah
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics in drug regulation: promise, potential and pitfallsRashmi R Shah
The New England Journal of Medicine|October 27, 2022
Spontaneous HyphemaParth R Shah
The Journal of Urology|December 25, 2012
Re: prostatic fibrosis is associated with lower urinary tract symptomsSharad R Shah
Journal of Clinical and Diagnostic Research : JCDR|September 13, 2017
Longitudinal Stent Deformation at Aneurysm Site: Flexibility at the Expense of Longitudinal IntegrityBhupesh R Shah
The Journal of the Association of Physicians of India|January 10, 2006
Understanding hepatitis BSamir R Shah
Drug Safety|February 10, 2017
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Rashmi R Shah
Pageof 319

Showing results (31-40 of 3,190) with videos related to

Sort By:
Pageof 319
Annals of Surgery|June 23, 2001
Re: Orozco et al. A comparative study of the elective treatment of variceal hemorrhage with beta-blockers, transendoscopic sclerotherapy and surgery. A prospective, controlled, and randomized trial during 10 years. Ann Surg 2000; 232:216-9S R Shah
Journal of Clinical Pharmacy and Therapeutics|March 14, 2020
Genotype-guided warfarin therapy: Still of only questionable value two decades onRashmi R Shah
Drug Safety|January 17, 2019
Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in OncologyRashmi R Shah
Novartis Foundation Symposium|July 30, 2005
Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studiesRashmi R Shah
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics in drug regulation: promise, potential and pitfallsRashmi R Shah
The New England Journal of Medicine|October 27, 2022
Spontaneous HyphemaParth R Shah
The Journal of Urology|December 25, 2012
Re: prostatic fibrosis is associated with lower urinary tract symptomsSharad R Shah
Journal of Clinical and Diagnostic Research : JCDR|September 13, 2017
Longitudinal Stent Deformation at Aneurysm Site: Flexibility at the Expense of Longitudinal IntegrityBhupesh R Shah
The Journal of the Association of Physicians of India|January 10, 2006
Understanding hepatitis BSamir R Shah
Drug Safety|February 10, 2017
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Rashmi R Shah
Pageof 319